Biotech

All Articles

Biogen's CEO mentioned no risky handle 2023. He's ready to become vibrant

.While Biogen's pharma peers are hunting for late-stage properties with little danger, CEO Chris Vie...

Instil refills pipe in $2B biobucks manage ImmunOnco

.Instil Bio has actually been actually a biotech trying to find a pipeline after it junked its own l...

Biogen walks away from Denali Alzheimer's collab

.Biogen has returned liberties to an early Alzheimer's ailment system to Denali Therapeutics, leavin...

Takeda water faucets brand new mind of US oncology organization-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our roundup of significant leadership hirings, firings a...

Vertex, hammered by AATD once more, goes down 2 possessions on discard pile

.Tip's effort to handle a rare genetic disease has actually reached one more setback. The biotech th...

Vir gains 3 T-cell engagers coming from Sanofi, lays off 25% of staff

.Vir Biotechnology's second-quarter earnings record wasn't except big updates. The business welcomed...

Galapagos stops briefly CAR-T cell therapy trial over Parkinsonism instance

.Galapagos has actually stopped briefly application in a test of a BCMA-directed CAR-T tissue treatm...

James Wilson leaving behind Penn to release 2 brand new biotechs

.After more than three decades, gene treatment innovator James Wilson M.D., Ph.D., is actually leavi...

3 biotechs attempt to trump the summer heat by shedding staff

.As biotechs attempt to switch a new webpage in August, at least 3 providers have actually dropped t...

venBio raises $528M for fifth life scientific researches VC fund

.Expert venture capital company venBio has lifted an additional half a billion dollars to invest in ...